#pharmacy-benefit-managers

#pharmacy-benefit-managers

New bipartisan legislation seeks to prevent health insurers from owning pharmacies, targeting the monopolistic power of pharmacy benefit managers.

If enacted, this legislation could disrupt the current healthcare market dominated by a few conglomerates. The effort highlights ongoing concerns about drug pricing and transparency.

FTC report reveals significant price hikes by PBMs on critical medications, calling for investigations into practices inflating drug costs and harming healthcare accessibility.

New law removes 'gag clause' for pharmacists, enhancing transparency on medication pricing and accessibility.

Congress' funding bill introduces key healthcare reforms targeting pharmacy benefit managers, telehealth access, and payment increases for hospitals and physicians.

Congress is advancing bills to dismantle major insurance monopolies following Brian Thompson's murder, reflecting significant public outrage towards the healthcare system.

Protests arise over health care denial issues, highlighting frustrations with profit-driven insurance, particularly after the assassination of UnitedHealthcare's CEO.

The role of pharmacy benefit managers (PBMs) in escalating drug costs remains largely unexamined by the public, despite their significant impact.